Wang-Wei Guo
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 2
- Metabolism, Diabetes, and Cancer 1
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Min Han (9 shared papers)Jianqing Gao (8 shared papers)Mengting Lin (7 shared papers)Jiejian Chen (7 shared papers)Ningning Guo (6 shared papers)Qichun Wei (6 shared papers)Ming-Yi Huang-Fu (4 shared papers)Wenhong Xu (4 shared papers)
In The Last Decade
Wang-Wei Guo
10 papers receiving 347 citations
Peers
Comparison fields: 5 of 57
- Biomaterials 197
- Biomedical Engineering 192
- Pharmaceutical Science 17
- Cancer Research 41
- Molecular Biology 174
Countries citing papers authored by Wang-Wei Guo
This map shows the geographic impact of Wang-Wei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang-Wei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang-Wei Guo more than expected).
Fields of papers citing papers by Wang-Wei Guo
This network shows the impact of papers produced by Wang-Wei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang-Wei Guo. The network helps show where Wang-Wei Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang-Wei Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 100 | |
| 2 | 2018 | 60 | |
| 3 | 2018 | 55 | |
| 4 | 2018 | 45 | |
| 5 | 2019 | 36 | |
| 6 | 2019 | 33 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 7 | |
| 9 | [Mitochondrial drug delivery for cancer therapy]. | 2016 | 4 |
| 10 | [Pharmacokinetics of injected cefozopran hydrochloride in healthy volunteers]. | 2012 | 2 |
About Wang-Wei Guo
Wang-Wei Guo is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Oncology and Cancer Research, having authored 10 papers that have together received 350 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Advanced biosensing and bioanalysis techniques (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Molecular Sensors and Ion Detection (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Biomaterials (197 citations), Biomedical Engineering (192 citations), Pharmaceutical Science (17 citations), Cancer Research (41 citations) and Molecular Biology (174 citations). Wang-Wei Guo has collaborated with scholars based in China and Canada. Frequent co-authors include Min Han, Jianqing Gao, Mengting Lin, Jiejian Chen, Ningning Guo, Qichun Wei, Ming-Yi Huang-Fu, Wenhong Xu, Afsaneh Lavasanifar and Mohammad Reza Vakili. Their work appears in journals such as Molecular Pharmaceutics, Acta Pharmacologica Sinica, Acta Biomaterialia, Biomacromolecules and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.